Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern

无症状或有症状的SARS-CoV-2感染加上接种疫苗可增强对相关变异株的适应性免疫力。

阅读:6
作者:Peifang Sun ,Irene Ramos ,Camila H Coelho ,Alba Grifoni ,Corey A Balinsky ,Sindhu Vangeti ,Alison Tarke ,Nathaniel I Bloom ,Vihasi Jani ,Silvia J Jakubski ,David A Boulifard ,Elizabeth Cooper ,Carl W Goforth ,Jan Marayag ,Amethyst Marrone ,Edgar Nunez ,Lindsey White ,Chad K Porter ,Victor A Sugiharto ,Megan Schilling ,Avinash S Mahajan ,Charmagne Beckett ,Alessandro Sette ,Stuart C Sealfon ,Shane Crotty ,Andrew G Letizia

Abstract

The ongoing evolution of SARS-CoV-2 requires monitoring the capability of immune responses to cross-recognize Variants of Concern (VOC). In this cross-sectional study, we examined serological and cell-mediated immune memory to SARS-CoV-2 variants, including Omicron, among a cohort of 18-21-year-old Marines with a history of either asymptomatic or mild SARS-CoV-2 infection 6 to 14 months earlier. Among the 210 participants in the study, 169 were unvaccinated while 41 received 2 doses of mRNA-based COVID-19 vaccines. Vaccination of previously infected participants strongly boosted neutralizing and binding activity and memory B and T cell responses including the recognition of Omicron, compared to infected but unvaccinated participants. Additionally, no measurable differences were observed in immune memory in healthy young adults with previous symptomatic or asymptomatic infections, for ancestral or variant strains. These results provide mechanistic immunological insights into population-based differences observed in immunity against Omicron and other variants among individuals with different clinical histories.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。